Published in Medical Devices and Surgical Technology Week, January 8th, 2006
"Long-term safety data were collected with the prospect of possible use of RT in liver cell transplantation (LCT)," noted X. Stephenne and coauthors at the Catholic University of Louvain. "Immune suppression included cyclosporine, azathioprine and prednisone."
"In case of intractable rejection, low-dose allograft RT was administered daily for 3 days, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.